Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
ORCHID PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   PCE(x) 41.3214.2638.52736.19-

What is the latest Price to Cash Earnings (PCE) ratio of ORCHID PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of ORCHID PHARMA is 41.32 based on Mar2024 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202441.32
Mar202314.26
Mar202238.52
Mar2021736.19
Mar2020-

How is Price to Cash Earnings (PCE) of ORCHID PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2024 41.32
189.76
Mar2023 14.26
-62.98
Mar2022 38.52
-94.77
Mar2021 736.19
0
Mar2020 0 -

Other Financial Ratios of ORCHID PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹3,851.2 Cr -1.2% 8.7% -45.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹389,172.0 Cr -1.2% -3.6% -8.6% Stock Analytics
DIVIS LABORATORIES ₹158,248.0 Cr -6.6% -12.4% 22.3% Stock Analytics
CIPLA ₹122,835.0 Cr 0.3% 1.2% -5.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,793.0 Cr 0.7% 9.1% 7.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,869.0 Cr 0.4% -2.8% -12.7% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-1.2%

8.7%

-45.8%

SENSEX

-0.6%

-2.8%

1.7%


You may also like the below Video Courses